In Sickness and in Health: A Shotgun Marriage That Is Flourishing

作者: Horst Flotow , Alex Matter

DOI: 10.1002/9781118778166.CH30

关键词: FlourishingAtazanavirAlternative medicineFamily medicineShotgunPharmacologyMedicine

摘要:

参考文章(74)
Valerio Tozzi, Pharmacogenetics of antiretrovirals. Antiviral Research. ,vol. 85, pp. 190- 200 ,(2010) , 10.1016/J.ANTIVIRAL.2009.09.001
Richard D. Press, Chad Galderisi, Rui Yang, Carole Rempfer, Stephanie G. Willis, Michael J. Mauro, Brian J. Druker, Michael W.N. Deininger, A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response. Clinical Cancer Research. ,vol. 13, pp. 6136- 6143 ,(2007) , 10.1158/1078-0432.CCR-07-1112
Bin Peng, Michael Hayes, Debra Resta, Amy Racine-Poon, Brian J. Druker, Moshe Talpaz, Charles L. Sawyers, Marianne Rosamilia, John Ford, Peter Lloyd, Renaud Capdeville, Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients Journal of Clinical Oncology. ,vol. 22, pp. 935- 942 ,(2004) , 10.1200/JCO.2004.03.050
Razelle Kurzrock, Hagop M. Kantarjian, Brian J. Druker, Moshe Talpaz, Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics Annals of Internal Medicine. ,vol. 138, pp. 819- 830 ,(2003) , 10.7326/0003-4819-138-10-200305200-00010
Robert F Spiera, Jessica K Gordon, Jamie N Mersten, Cynthia M Magro, Mansi Mehta, Horatio F Wildman, Stacey Kloiber, Kyriakos A Kirou, Stephen Lyman, Mary K Crow, Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial Annals of the Rheumatic Diseases. ,vol. 70, pp. 1003- 1009 ,(2011) , 10.1136/ARD.2010.143974
Gilbert Kokwaro, Ongoing challenges in the management of malaria. Malaria Journal. ,vol. 8, pp. 1- 6 ,(2009) , 10.1186/1475-2875-8-S1-S2
S. Flamant, W. Ritchie, J. Guilhot, J. Holst, M.-L. Bonnet, J.-C. Chomel, F. Guilhot, A. G. Turhan, J. E. J. Rasko, Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia Haematologica. ,vol. 95, pp. 1325- 1333 ,(2010) , 10.3324/HAEMATOL.2009.020636
Mark A Pearson, Doriano Fabbro, Targeting protein kinases in cancer therapy: a success? Expert Review of Anticancer Therapy. ,vol. 4, pp. 1113- 1124 ,(2004) , 10.1586/14737140.4.6.1113